Search results
Chronic Lyme Disease: Why COVID May Spark Better Tests and Treatment
Well and Good· 24 hours agoPeople with chronic Lyme disease (or PTLDS) are understudied and have limited treatment options, but...
Climate change linked to longer, harsher allergy seasons
Midland Reporter-Telegram· 16 hours ago“There’s no question [that] as there’s global warming, the pollen season is increasing,” said Sanjiv...
OCT Europe: Unless everyone is benefiting, what is the point?
Pharmaceutical Technology via Yahoo Finance· 23 hours agoHead of the late phase programme management respiratory and immunology at AstraZeneca, Alina...
Fighting fat and inflammation: Scientists develop new compounds
Medical Xpress· 15 hours agoIn a recent study, a team of researchers led by Professor Gen-ichiro Arimura from the Department of...
‘Quantum internet’ demonstration in cities is most advanced yet
Nature· 1 day agoExperiments generate quantum entanglement over optical fibres across three real cities, marking...
Mutations protected mice from B-cell cancers | Newswise
Newswise· 2 days ago“We used a purely genetic method to find a drug target, and that target turns out to be sensational...
Researchers determine the mutations that protect mice from B-cell cancers
Medical Xpress· 21 hours agoDr. Beutler, who shared the 2011 Nobel Prize in Physiology or Medicine for his discovery of an important family of pathogen sensors...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Johnson Investment Counsel Inc.
ETF DAILY NEWS· 1 day agoJohnson Investment Counsel Inc. cut its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 12.4% in the 4th quarter, according to the company in its most recent disclosure with ...
Study Offers Clues on Asthma Control for Patients With Concurrent Diabetes
MedPage Today· 6 days agoHowever, patients taking SGLT2 inhibitors had similar incidences of asthma exacerbations that required use of systemic corticosteroids compared with metformin (17.3 vs 18.1 per 100 person-years ...
Nektar Therapeutics Reports First Quarter 2024 Financial Results
Coronado Eagle & Journal· 7 days agoCash and investments in marketable securities at March 31, 2024 were $326.0 million as compared to $329.4 million at December 31, 2023. Nektar's cash and marketable securities are expected to ...